INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$0

$0

Total Sells (Filtered)

$988K

$988,983

View Raw Line-Items

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
TVTX S Travere Therapeutics, Inc. Cline Christopher R. • CFO 10b5-1 Sell 2026-02-04 $56,168x2 View Form 4 →
TVTX	Travere Therapeutics, Inc.	Cline Christopher R. CFO 10b5-1 Sell	2026-02-04	$56,168x2	S	Form 4
TVTX S Travere Therapeutics, Inc. Cline Christopher R. • CFO Sell to Cover 2026-02-03 $232,613 View Form 4 →
TVTX	Travere Therapeutics, Inc.	Cline Christopher R. CFO Sell to Cover	2026-02-03	$232,613	S	Form 4
TVTX M Travere Therapeutics, Inc. Cline Christopher R. • CFO Equity Compensation 2025-12-01 $324,600x2 View Form 4 →
TVTX	Travere Therapeutics, Inc.	Cline Christopher R. CFO Equity Compensation	2025-12-01	$324,600x2	M	Form 4
TVTX S Travere Therapeutics, Inc. Cline Christopher R. • CFO 10b5-1 SellΔOwn -17.8% 2025-12-01 $700,202 View Form 4 →
TVTX	Travere Therapeutics, Inc.	Cline Christopher R. CFO 10b5-1 SellΔOwn -17.8%	2025-12-01	$700,202	S	Form 4